Drugs / Milnacipram
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01288807 | Feb 2011 → Jan 2015 | fibromyalgia | University of California, San Diego | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Milnacipram | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01288807 ↗ |
| Action | Inhibit | “Milnacipran, a NE and 5HT reuptake inhibitor” NCT01288807 ↗ |
| Route | Oral | “Titration to 200mg PO daily” NCT01288807 ↗ |